Breaking News

Tweet TWEET

Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Incyte Corporation

  Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class
  Action Lawsuit Against Incyte Corporation

Business Wire

LOS ANGELES -- April 12, 2013

Glancy Binkow & Goldberg LLP announces that purchasers of the common stock of
Incyte Corporation (“Incyte” or the “Company”) (NASDAQ:INCY) between April 26,
2012 and August 1, 2012 (the “Class Period’) have until May 6, 2013 to file a
motion with the Court to be appointed as lead plaintiff. The shareholder
lawsuit was filed in the United States District Court for the District of
Delaware.

Incyte, a biopharmaceutical company, focuses on the discovery, development and
commercialization of proprietary small molecule drugs for oncology and
treatment of inflammation. The Complaint alleges that Incyte issued misleading
statements concerning demand for the Company’s myelofibrosis drug, Jakafi.

On August 2, 2012 Incyte announced the Company’s second quarter 2012 financial
results and disclosed that the sales growth of Jakafi had been much softer
during the second quarter of 2012 than investors and certain stock analysts
had been led to expect. In response to these disclosures, the price of Incyte
stock declined 22% from its August 1, 2012 close of $24.92 per share, to close
at $19.57 per share on August 2, 2012 on heavy trading volume.

If you are a member of the Class described above, you have until May 6, 2013
to move the Court to serve as lead plaintiff; however, you must meet certain
legal requirements. To be a member of the Class you need not take action at
this time; you may retain counsel of your choice or take no action and remain
an absent Class member. To learn more about this action, or if you have any
questions concerning this Notice or your rights or interests with respect to
these matters, please contact Michael Goldberg, Esquire, of Glancy Binkow &
Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California
90067, by telephone at (310) 201-9150, Toll Free at (888) 773-9224, by e-mail
to shareholders@glancylaw.com, or visit our website at
http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

Contact:

Glancy Binkow & Goldberg LLP, Los Angeles, CA
Michael Goldberg
310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com